The following is a summary of “Association between incretin-based drugs and risk of cholangiocarcinoma among patients with ...
During JPM week, virtual care companies strut their plans to make GLP-1 drugs work harder, cost less
Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...
In a large population of people with diabetes, the use of GLP-1 receptor agonists was not linked to an increased risk for ...
Patients with overweight or obesity who used maridebart cafraglutide experienced significant weight loss at 1 year, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback